NYSE Euronext Announces Trading Volumes for October 2009

http://www.businesswire.com/news/home/20091105006711/en

October Trading Volumes Mostly Lower Versus Record Prior Year Levels;

U.S. Options Market Share Increases to 22.8%; Third Consecutive Monthly Increase
in European Cash Trading Volumes
NEW YORK--(Business Wire)--
NYSE Euronext (NYX) today announced trading volumes for its global cash equities
and derivatives exchanges for October 20091. Trading volumes in October 2009
were mostly lower compared to October 2008 levels, during which crisis-level
volatility drove record trading volumes. Trading volumes compared to September
2009 were mixed, with U.S. options and European cash increasing 6.3% and 7.1%,
respectively, and European derivatives and U.S. cash decreasing, 11.1% and 3.3%,
respectively.

Highlights

* NYSE Euronext European derivatives products average daily volume ("ADV") in
October 2009 of 3.9 million contracts decreased 12.9% compared to October 2008,
and decreased 11.1% from September 2009. Total interest rate products ADV in
October 2009 of 2.0 million contracts decreased 9.5% compared to October 2008
and total equity products ADV of 1.8 million contracts decreased 16.9% compared
to October 2008.
* NYSE Euronext U.S. equity options ADV of 3.2 million contracts in October 2009
increased 23.3% compared to October 2008 levels, and increased 6.3% from
September 2009. NYSE Euronext`s U.S. options exchanges accounted for 22.8% of
the total consolidated equity options trading in October 2009, up from 17.6% in
October 2008, and up from 21.4% in September 2009.
* NYSE Liffe U.S. futures and futures options ADV in October 2009 of
approximately 22,000 contracts increased from approximately 21,000 contracts in
September 2009 with the launch of equity index futures trading in September 2009
based on the MSCI U.S., EM and EAFE indexes.
* NYSE Euronext European cash products ADV of 1.6 million transactions in
October 2009 decreased 26.1% compared to October 2008, but increased 7.1% from
September 2009 and represented the third consecutive monthly increase in trading
volumes since July with market share stable at approximately 78%.
* NYSE, NYSE Arca and NYSE Amex ("NYSE Group") U.S. cash products handled ADV of
2.9 billion shares in October 2009 decreased 38.9% compared to October 2008 and
decreased 3.3% compared to September 2009. NYSE Group matched share of all U.S.
equity trading volume in October 2009 was 28.1%, up from 28.0% in September
2009, and compared to matched market share of 24.7% for our next largest
competitor. NYSE Group`s Tape A matched market share in October 2009 was 36.6%,
up from 36.1% in September 2009.
* NYSE Euronext is the largest exchange operator in the two fastest growing
tapes in the U.S. equity markets. Year-to-date, total Tape A and Tape B
consolidated ADV of 7.9 billion shares increased a combined 23.6%, compared to
the prior year period, while Tape C consolidated ADV of 2.3 billion shares has
declined 0.9% during the same period.

Derivatives Trading

European Derivatives

* NYSE Euronext European derivatives products ADV in October 2009 was 3.9
million futures and options contracts, a decrease of 12.9% from October 2008,
and a decrease of 11.1% from the 4.4 million contracts recorded in September
2009. The 3.9 million in futures and options contracts ADV in October 2009
consisted of 3.3 million contracts executed through our full-service LIFFE
CONNECT trading platform and 0.6 million, or 15.6%, executed through Bclear,
NYSE Liffe's trade administration and clearing service for OTC products.
Year-to-date European derivatives products ADV of 4.1 million contracts was 3.3%
below prior year levels.
* Total interest rate products ADV of 2.0 million contracts in October 2009
decreased 9.5% and 12.7% from October 2008 and September 2009, respectively.
Year-to-date, total interest rate products ADV decreased 12.4% compared to the
prior year period.
* Total equity products (including Bclear) ADV of 1.8 million contracts in
October 2009 decreased 16.9% compared to October 2008, and decreased 9.7%
compared to September 2009. Year-to-date total equity products ADV increased
7.9% from the prior year period driven primarily by a 37.0% increase in volume
executed through Bclear.

U.S. Derivatives

* NYSE Group U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.2 million
contracts in October 2009 increased 23.3% compared to October 2008 and increased
6.3% compared to September 2009. The increase in ADV year-over-year and compared
to September 2009 was driven in part by increased trading related to the
anticipated sale of an equity stake in NYSE Amex Options and NYSE Amex Options
pricing changes implemented July 1, 2009.
* Year-to-date, NYSE Group U.S. equity options volume of 2.6 million contracts
was 47.5% above the prior year period driven in part by the addition of the
former Amex options business.
* Total U.S. consolidated options ADV decreased 4.8% to 13.9 million contracts
in October 2009, and was flat compared to September 2009. Year-to-date, U.S.
consolidated options ADV of 13.6 million contracts was 0.7% above the prior year
period.
* NYSE Euronext`s U.S. options exchanges accounted for 22.8% of the total
consolidated equity options trading in October 2009, up from 17.6% in October
2008, and up from 21.4% in September 2009. The increase in market share
year-over-year and compared to September was driven in part by increased trading
related to the anticipated sale of an equity stake in NYSE Amex Options and NYSE
Amex Options pricing changes implemented July 1, 2009.
* NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in
October 2009 of approximately 22,000 contracts increased from approximately
21,000 contracts in September 2009 with the launch of equity index futures
trading in September based on the MSCI U.S., EM and EAFE indexes.

Cash Trading

European Cash

* NYSE Euronext European cash products ADV of 1.6 million transactions in
October 2009 decreased 26.1%, compared to October 2008, but increased 7.1%
compared to September 2009 and represented the third consecutive monthly
increase in ADV since July with market share stable at approximately 78%.
Year-to-date, European cash products ADV of 1.4 million transactions was 12.0%
below the same period last year.

U.S. Cash

* NYSE Group U.S. cash products handled ADV in October 2009 decreased 38.9% to
2.9 billion shares, compared to October 2008, and decreased 3.3% from September
2009. Year-to-date, NYSE Group handled ADV of 3.5 billion shares was 1.3% below
the same period last year.
* NYSE Group matched share of all U.S. equity volume in October 2009 was 28.1%,
compared to matched market share of 24.7% for our next largest competitor.
* Consolidated Tape A and Tape B trading volume in October 2009 accounted for
approximately 75% of all Consolidated Tape trading in the U.S. market which
includes trade reporting facility ("TRF") volumes.

NYSE-listed (Tape A)

* NYSE Group`s Tape A matched market share in October 2009 was 36.6%, up from
36.1% in September 2009, and compared to matched market share of 19.5% for our
next largest competitor. Tape A matched market share for NYSE was 25.1% in
October 2009, above the 24.5% market share reported in October 2008. TRF market
share across Tape A was 33.2%, down from 37.6% in August 2009, but up from 25.0%
in December 2008.
* Designated Market Maker ("DMM") participation in October 2009 was 9.3%,
compared to 9.1% in September 2009. Supplemental Liquidity Provider ("SLP")
participation in October 2009 was 10.3%, compared to 9.5% in September 2009. A
total of 7 SLPs are now on the platform. DMM and SLP participation pertain only
to trading on NYSE.

NYSE Arca and NYSE Amex-listed (Tape B)

* Tape B matched market share of NYSE Group in October 2009 was 22.5%, down from
22.6% in September 2009, compared to matched market share of 27.3% for our
nearest competitor. TRF market share across Tape B in October 2009 was 32.6%
compared to 21.5% in December 2008.

Nasdaq-listed (Tape C)

* NYSE Group`s Tape C matched market share in October 2009 increased to 12.3%
from 12.2% in September 2009, compared to matched market share of 34.6% for our
nearest competitor. TRF market share across Tape C in October 2009 was 38.9%
compared to 29.9% in December 2008.

Exchange Traded Products

* NYSE Group matched exchange-traded products ADV (included in volumes from Tape
B and Tape C noted above) of 346 million shares in October 2009 decreased 54.3%
compared to October 2008, but increased 9.1% compared to September 2009.
Year-to-date, matched exchange-traded products ADV was 11.5% above the prior
year period.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and
provider of innovative trading technologies. The company's exchanges in Europe
and the United States trade equities, futures, options, fixed-income and
exchange-traded products. With more than 8,000 listed issues, NYSE Euronext's
equities markets -- the New York Stock Exchange, Euronext, NYSE Arca and NYSE
Amex -- represent nearly 40 percent of the world's equities trading, the most
liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe,
the leading European derivatives business and the world's second-largest
derivatives business by value of trading. The company offers comprehensive
commercial technology, connectivity and market data products and services
through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the
only exchange operator in the S&P 100 index and Fortune 500. For more
information, please visit: www.nyx.com

Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements include, but are
not limited to, statements concerning NYSE Euronext`s plans, objectives,
expectations and intentions and other statements that are not historical or
current facts. Forward-looking statements are based on NYSE Euronext`s current
expectations and involve risks and uncertainties that could cause actual results
to differ materially from those expressed or implied in such forward-looking
statements. Factors that could cause NYSE Euronext`s results to differ
materially from current expectations include, but are not limited to: NYSE
Euronext`s ability to implement its strategic initiatives, economic, political
and market conditions and fluctuations, government and industry regulation,
interest rate risk and U.S. and global competition, and other factors detailed
in NYSE Euronext`s reference document for 2008 ("document de référence") filed
with the French Autorité des Marchés Financiers (Registered on April 28, 2009
under No. R. 09-031), 2008 Annual Report on Form 10-K and other periodic reports
filed with the U.S. Securities and Exchange Commission or the French Autorité
des Marchés Financiers. In addition, these statements are based on a number of
assumptions that are subject to change. Accordingly, actual results may be
materially higher or lower than those projected. The inclusion of such
projections herein should not be regarded as a representation by NYSE Euronext
that the projections will prove to be correct. This press release speaks only as
of this date. NYSE Euronext disclaims any duty to update the information herein.

1 Euronext equities transactions count each buy and sell order as separate
transactions, NYSE Group equities transactions count buy and sell orders
together as a single transaction. All NYSE Euronext derivatives transactions
count buy and sell orders together as a single transaction.

NYSE Euronext
Monthly Volume Summary - Cash Products

Average Daily Volume Total Volume Average Daily Volume Total Volume
(Unaudited) Oct-09 Oct-08 % Chg Oct-09 Oct-08 % Chg YTD 2009 % Chg vs. YTD 2009 % Chg vs.

YTD 2008
YTD 2008

Number of Trading Days - European Markets 22 23 22 23 213 213
Number of Trading Days - U.S. Markets 22 23 22 23 210 210

European Cash Products (trades in thousands) 1,580 2,138 -26.1 % 34,758 49,173 -29.3 % 1,402 -12.0 % 298,617 -12.8 %

Equities 1,516 2,070 -26.8 % 33,358 47,617 -29.9 % 1,343 -12.8 % 285,994 -13.6 %
Exchange-Traded Funds 17 16 4.8 % 378 377 0.3 % 14 65.6 % 3,072 64.0 %
Structured Products 40 46 -12.4 % 883 1,054 -16.2 % 39 -1.4 % 8,342 -2.3 %
Bonds 6 5 16.1 % 139 126 11.0 % 6 8.4 % 1,209 7.4 %

U.S. Cash Products (shares in millions) 2 2,922 4,783 -38.9 % 64,279 110,019 -41.6 % 3,460 -1.3 % 726,563 -2.2 %

NYSE Listed (Tape A) Issues 1

NYSE Group Handled Volume 2 2,147 3,364 -36.2 % 47,238 77,383 -39.0 % 2,525 -2.1 % 530,154 -3.0 %
NYSE Group Matched Volume 3 1,972 3,023 -34.8 % 43,389 69,535 -37.6 % 2,293 -1.4 % 481,508 -2.3 %
Total NYSE Listed Consolidated Volume 5,388 7,052 -23.6 % 118,535 162,186 -26.9 % 5,932 17.8 % 1,245,760 16.7 %

NYSE Group Share of Total Consolidated Volume
Handled Volume 2 39.9 % 47.7 % -7.8 % 39.9 % 47.7 % -7.8 % 42.6 % -8.6 % 42.6 % -8.6 %
Matched Volume 3 36.6 % 42.9 % -6.3 % 36.6 % 42.9 % -6.3 % 38.7 % -7.5 % 38.7 % -7.5 %

NYSE Arca & Amex (Tape B) Listed Issues

NYSE Group Handled Volume 2 418 844 -50.5 % 9,189 19,421 -52.7 % 549 19.7 % 115,284 18.5 %
NYSE Group Matched Volume 3 365 726 -49.7 % 8,034 16,707 -51.9 % 480 20.6 % 100,818 19.5 %
Total NYSE Arca & Amex Listed Consolidated Volume 1,625 2,399 -32.3 % 35,741 55,170 -35.2 % 1,999 44.7 % 419,824 43.3 %

NYSE Group Share of Total Consolidated Volume
Handled Volume 2 25.7 % 35.2 % -9.5 % 25.7 % 35.2 % -9.5 % 27.5 % -5.7 % 27.5 % -5.7 %
Matched Volume 3 22.5 % 30.3 % -7.8 % 22.5 % 30.3 % -7.8 % 24.0 % -4.8 % 24.0 % -4.8 %

Nasdaq Listed (Tape C) Issues

NYSE Group Handled Volume 2 357 575 -37.9 % 7,852 13,215 -40.6 % 386 -17.2 % 81,125 -18.0 %
NYSE Group Matched Volume 3 288 485 -40.6 % 6,339 11,164 -43.2 % 315 -19.5 % 66,171 -20.2 %
Total Nasdaq Listed Consolidated Volume 2,335 2,796 -16.5 % 51,363 64,302 -20.1 % 2,302 -0.9 % 483,508 -1.8 %

NYSE Group Share of Total Consolidated Volume
Handled Volume 2 15.3 % 20.6 % -5.3 % 15.3 % 20.6 % -5.3 % 16.8 % -3.3 % 16.8 % -3.3 %
Matched Volume 3 12.3 % 17.4 % -5.1 % 12.3 % 17.4 % -5.1 % 13.7 % -3.1 % 13.7 % -3.1 %

Exchange-Traded Funds 1,4

NYSE Group Handled Volume 2 395 872 -54.7 % 8,697 20,056 -56.6 % 539 11.1 % 113,193 10.1 %
NYSE Group Matched Volume 3 346 758 -54.3 % 7,623 17,426 -56.3 % 473 11.5 % 99,244 10.5 %
Total ETF Consolidated Volume 1,592 2,602 -38.8 % 35,029 59,844 -41.5 % 2,018 38.0 % 423,877 36.7 %

NYSE Group Share of Total Consolidated Volume
Handled Volume 2 24.8 % 33.5 % -8.7 % 24.8 % 33.5 % -8.7 % 26.7 % -6.5 % 26.7 % -6.5 %
Matched Volume 3 21.8 % 29.1 % -7.3 % 21.8 % 29.1 % -7.3 % 23.4 % -5.6 % 23.4 % -5.6 %

NYSE Euronext
Monthly Volume Summary - Derivatives Products

Average Daily Volume Total Volume Average Daily Volume Total Volume
(Unaudited; contracts in thousands) Oct-09 Oct-08 % Chg Oct-09 Oct-08 % Chg YTD 2009 % Chg vs. YTD 2009 % Chg vs.

YTD 2008
YTD 2008

Number of Trading Days - European Markets 22 23 22 23 213 213
Number of Trading Days - U.S. Markets 22 23 22 23 210 210

European Derivatives Products 3,871 4,447 -12.9 % 85,173 102,270 -16.7 % 4,119 -3.3 % 877,282 -4.2 %
of which Bclear 604 664 -9.1 % 13,285 15,276 -13.0 % 1,023 37.0 % 217,849 35.7 %

Total Interest Rate Products 1,992 2,201 -9.5 % 43,824 50,612 -13.4 % 2,014 -12.4 % 428,949 -13.2 %

Short Term Interest Rate Products 1,881 2,107 -10.7 % 41,376 48,455 -14.6 % 1,914 -12.8 % 407,587 -13.6 %
Medium and Long Term Interest Rate Products 5 111 94 18.7 % 2,448 2,157 13.5 % 100 -4.3 % 21,361 -5.2 %

Total Credit Derivatives Products (Bclear) - - - - - -

Total Equity Products 6 1,824 2,195 -16.9 % 40,118 50,485 -20.5 % 2,057 7.9 % 438,115 6.9 %

Individual Equity Products 1,197 1,253 -4.5 % 26,332 28,829 -8.7 % 1,439 17.5 % 306,462 16.4 %
Equity Index Products 627 942 -33.4 % 13,786 21,656 -36.3 % 618 -9.4 % 131,653 -10.3 %

of which Bclear 604 664 -9.1 % 13,285 15,276 -13.0 % 1,023 37.0 % 217,849 35.7 %
Individual Equity Products 475 503 -5.5 % 10,461 11,570 -9.6 % 891 40.4 % 189,841 39.1 %
Equity Index Products 128 161 -20.3 % 2,824 3,706 -23.8 % 131 17.6 % 28,008 16.5 %

Commodity Products 56 51 9.7 % 1,230 1,172 4.9 % 48 -11.0 % 10,218 -11.8 %
of which Bclear - - - - - -

U.S. Derivatives Products

Equity Options 7

NYSE Group Options Contracts 3,185 2,584 23.3 % 70,074 59,429 17.9 % 2,559 47.5 % 537,482 46.1 %
Total Consolidated Options Contracts 13,942 14,644 -4.8 % 306,729 336,805 -8.9 % 13,573 0.7 % 2,850,277 -0.3 %

NYSE Group Share of Total 22.8 % 17.6 % 22.8 % 17.6 % 18.9 % 6.0 % 18.9 % 5.3 %

NYSE Liffe U.S.

Futures and Futures Options Volume 22.1 - 485.2 - 17.1 - 3,598.6 -

1 Includes all volume executed in NYSE Group crossing sessions.
2 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.
3 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.
4 Data included in previously identified categories.
5 Data includes currency products.
6 Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.
7 Includes trading in U.S. equity options contracts, not equity-index options.

Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.
All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.
US Equities data has been updated for Amex integration for October 2008 forward.

NYSE Euronext
Media:
+31.20.550.4488 (Amsterdam), +32.2.509.1392 (Brussels)
+351.217.900.029 (Lisbon), +44.20.7379.2789 (London)
+1.212.656.2411 (New York), +33.1.49.27.11.33 (Paris)
or
Investor Relations:
+1.212.656.5700 (New York)
+33.1.49.27.58.60 (Paris)

Copyright Business Wire 2009